menu
    • menu
    [{"orgOrder":0,"company":"Kirin Holdings","sponsor":"Biofortis Clinical Research, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JAPAN","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kirin Holdings","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kirin Holdings \/ Biofortis Clinical Research, Inc.","highestDevelopmentStatusID":"1","companyTruncated":"Kirin Holdings \/ Biofortis Clinical Research, Inc."},{"orgOrder":0,"company":"Kirin Holdings","sponsor":"The Center for Applied Health Sciences","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JAPAN","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kirin Holdings","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kirin Holdings \/ The Center for Applied Health Sciences","highestDevelopmentStatusID":"1","companyTruncated":"Kirin Holdings \/ The Center for Applied Health Sciences"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"University of Cincinnati","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JAPAN","productType":"Dietary Supplement","year":"2016","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ University of Cincinnati","highestDevelopmentStatusID":"1","companyTruncated":"Kyowa Hakko Bio \/ University of Cincinnati"},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Biofortis Clinical Research, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JAPAN","productType":"Dietary Supplement","year":"2017","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Biofortis Clinical Research, Inc.","highestDevelopmentStatusID":"1","companyTruncated":"Kyowa Hakko Bio \/ Biofortis Clinical Research, Inc."},{"orgOrder":0,"company":"Kyowa Hakko Bio","sponsor":"Oregon Health and Science University","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"JAPAN","productType":"Dietary Supplement","year":"2018","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kyowa Hakko Bio","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kyowa Hakko Bio \/ Oregon Health and Science University","highestDevelopmentStatusID":"1","companyTruncated":"Kyowa Hakko Bio \/ Oregon Health and Science University"},{"orgOrder":0,"company":"Centre Hospitalier Universitaire de Nice","sponsor":"DENSMORE pharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"FRANCE","productType":"Dietary Supplement","year":"2011","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Oncology","graph2":"Undisclosed","graph3":"Centre Hospitalier Universitaire de Nice","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Powder for Solution","sponsorNew":"Centre Hospitalier Universitaire de Nice \/ DENSMORE pharmaceuticals","highestDevelopmentStatusID":"1","companyTruncated":"Centre Hospitalier Universitaire de Nice \/ DENSMORE pharmaceuticals"},{"orgOrder":0,"company":"Omikron Italia","sponsor":"OPIS Spain","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"ITALY","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Ophthalmology","graph2":"Phase III","graph3":"Omikron Italia","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Solution","sponsorNew":"Omikron Italia \/ OPIS Spain","highestDevelopmentStatusID":"10","companyTruncated":"Omikron Italia \/ OPIS Spain"},{"orgOrder":0,"company":"VivaTech International, Inc.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Dietary Supplement","year":"2016","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Musculoskeletal","graph2":"Phase II","graph3":"VivaTech International, Inc.","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Injection","sponsorNew":"VivaTech International, Inc. \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"VivaTech International, Inc. \/ Undisclosed"},{"orgOrder":0,"company":"VivaTech International, Inc.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Dietary Supplement","year":"2016","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Musculoskeletal","graph2":"Phase II","graph3":"VivaTech International, Inc.","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Injection","sponsorNew":"VivaTech International, Inc. \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"VivaTech International, Inc. \/ Undisclosed"},{"orgOrder":0,"company":"VivaTech International, Inc.","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Dietary Supplement","year":"2016","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Musculoskeletal","graph2":"Phase II","graph3":"VivaTech International, Inc.","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Injection","sponsorNew":"VivaTech International, Inc. \/ Undisclosed","highestDevelopmentStatusID":"8","companyTruncated":"VivaTech International, Inc. \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals for Citicoline Sodium

    Menu

    Citicoline Sodium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Kirin Holdings

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Kirin Holdings

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : The Center for Applied Health Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Evaluate the Effects of Citicoline on Mood in Healthy Adults

                            Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of unspecified medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 28, 2025

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : The Center for Applied Health Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Omikron Italia

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Omikron Italia

                            Italy arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Ophthalmology

                            Study Phase : Phase III

                            Sponsor : OPIS Spain

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma

                            Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Glaucoma, Open-Angle.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            February 02, 2023

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Phase III

                            Sponsor : OPIS Spain

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Kirin Holdings

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Kirin Holdings

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Biofortis Clinical Research, Inc.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Cognitive Effects of Citicoline on Attention in Healthy Mean and Women

                            Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 19, 2021

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Biofortis Clinical Research, Inc.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Kyowa Hakko Bio

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Kyowa Hakko Bio

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Oregon Health and Science University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Combination Effect of Citicoline and Omega-3

                            Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            February 23, 2018

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Oregon Health and Science University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Kyowa Hakko Bio

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Kyowa Hakko Bio

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Biofortis Clinical Research, Inc.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment

                            Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            December 12, 2017

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Biofortis Clinical Research, Inc.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            VivaTech International, Inc.

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            VivaTech International, Inc.

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the...

                            Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Osteoarthritis.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 26, 2016

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            VivaTech International, Inc.

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            VivaTech International, Inc.

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the...

                            Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Osteoarthritis.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 26, 2016

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            VivaTech International, Inc.

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            VivaTech International, Inc.

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the...

                            Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Osteoarthritis.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 26, 2016

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Phase II

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            09

                            Kyowa Hakko Bio

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Kyowa Hakko Bio

                            Japan arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : University of Cincinnati

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Citicoline Effects on Cortical Membrane Structure and Function

                            Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            March 10, 2016

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : University of Cincinnati

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            10

                            Centre Hospitalier Universitaire de Nice

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Centre Hospitalier Universitaire de Nice

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Oncology

                            Study Phase : Undisclosed

                            Sponsor : DENSMORE pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Influence of Oral Treatment With Citicoline for the Prevention of Radiation Optic Neuropathy in Patients Treat...

                            Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Uveal Melanoma.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            April 19, 2011

                            Lead Product(s) : Citicoline Sodium

                            Therapeutic Area : Oncology

                            Highest Development Status : Undisclosed

                            Sponsor : DENSMORE pharmaceuticals

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth